GSA Capital Partners’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-27,684
| Closed | -$238K | – | 1742 |
|
|
2025
Q1 | $238K | Buy |
+27,684
| New | +$238K | 0.02% | 1301 |
|
|
2024
Q4 | – | Sell |
-89,299
| Closed | -$507K | – | 1602 |
|
|
2024
Q3 | $507K | Sell |
89,299
-131,561
| -60% | -$747K | 0.04% | 896 |
|
|
2024
Q2 | $932K | Buy |
220,860
+199,965
| +957% | +$844K | 0.07% | 551 |
|
|
2024
Q1 | $106K | Buy |
+20,895
| New | +$106K | 0.01% | 1486 |
|
|
2023
Q3 | – | Sell |
-44,139
| Closed | -$359K | – | 1489 |
|
|
2023
Q2 | $359K | Buy |
+44,139
| New | +$359K | 0.04% | 942 |
|
|
2021
Q4 | – | Sell |
-30,301
| Closed | -$544K | – | 1405 |
|
|
2021
Q3 | $544K | Buy |
30,301
+13,298
| +78% | +$239K | 0.06% | 650 |
|
|
2021
Q2 | $389K | Buy |
+17,003
| New | +$389K | 0.04% | 787 |
|
|
2021
Q1 | – | Sell |
-49,678
| Closed | -$268K | – | 1092 |
|
|
2020
Q4 | $268K | Buy |
49,678
+20,194
| +68% | +$109K | 0.04% | 806 |
|
|
2020
Q3 | $134K | Buy |
+29,484
| New | +$134K | 0.02% | 1088 |
|